Over 50,000 children in the US avoided being diagnosed with deadly peanut allergies after they were exposed to the allergen ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data ...

Amelia said: “From the age of 16, I've always worked two jobs. In October last year, I got signed off work. They said that I ...

The FDA rounded out the month with the approval of remibrutinib (Rhapside; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for patients with chronic spontaneous urticaria (CSU) ...

FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix’s investigational intranasal potentiated oxytocin ...

Often fuelled by a dire shortage of qualified nurses and the weak enforcement of health regulations, auxiliary nurses - ...

FOCUS is a randomized, double-blind, placebo-controlled crossover pilot study evaluating Tonix's investigational intranasal potentiated oxytocin products in patients with Arginine-Vasopressin Deficien ...

The iconic Oscar Mayer Wienermobile is headed to Coastal Georgia in the coming weeks. Here's where and when you'll be able to see it. The Weinermobile dates back to the 1930s and is one of the most ...

Neuroscientist Gerald Voelbel’s journey from mysterious symptoms to a rare cancer and neurological disorder diagnosis ...

The emotional strain on parents and other caregivers faced with deciding whether a tracheotomy is the best treatment for ...

Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, Octobe ...